PREMIER Biosoft logo  
Home >> Company >> News >> PREMIER Biosoft Delivers Sigma-Aldrich Version 4.0 of OligoArchitect™ Online
PREMIER Biosoft Facebook link PREMIER Biosoft Twitter link
News  

PREMIER Biosoft today announced the successful delivery of OligoArchitect™ Online v4.0 to Sigma-Aldrich

Palo Alto, California -- September 04, 2013: PREMIER Biosoft, as a part of its contract software development services, has delivered OligoArchitect™ Online v4.0 to Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich. Sigma-Aldrich, with operations in over 40 countries, is a life science and high technology company. Its chemical and biochemical products are used in scientific research and as key components in high technology manufacturing.

This release of version 4.0 of OligoArchitect™ Online offers added LNA® base substitution in Dual-Labeled Probe, Molecular Beacon and LightCycler® Probe design modules.

"By introducing LNA design capabilities into OligoArchitect Online, a wide range of customers can now gain access to this chemistry. PREMIER Biosoft is now our trusted vendor, after demonstrating exemplary delivery of former versions of OligoArchitect and OligoEvaluator™," said Tom Russell, Product Manager at Sigma Life Science.

"After the successful launch of version 3.0 of OligoArchitect, Sigma further raised the bar by requesting support for LNA design. Our goal is to offer Sigma customers the best possible user experience and robust design algorithms," said Arun Apte, CEO, PREMIER Biosoft.

About PREMIER Biosoft
Founded in 1994, is a group of computer scientists and biologists dedicated to producing cutting edge intuitive software for research in life sciences. Our goal is to study the most recent innovations in life sciences and translate them into software products to aid research.

More information is available at: http://www.premierbiosoft.com.

Contact:
Shonali Paul
PREMIER Biosoft
650-856-2703
http://www.premierbiosoft.com

 
Copyright ©1994- PREMIER Biosoft. All rights reserved.